Back to today’s briefing

Story perspectives

Harvard Study: Single BRCA1 Mutation Elevates Cancer Risk

1/20/2025

50 8

Summary

Story summary

A groundbreaking study from Harvard Medical School reveals that just one mutation in the BRCA1 gene can drive cells toward cancer, overturning the long-held two-hit hypothesis. By examining genetically engineered mice, researchers uncovered that chromatin alterations linked to this mutation heighten tumor risk, paving the way for innovative therapies targeting BRCA1-related breast cancer.

1 of 1

Story summary

A groundbreaking study from Harvard Medical School reveals that just one mutation in the BRCA1 gene can drive cells toward cancer, overturning the long-held two-hit hypothesis. By examining genetically engineered mice, researchers uncovered that chromatin alterations linked to this mutation heighten tumor risk, paving the way for innovative therapies targeting BRCA1-related breast cancer.